BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 5, 2013
View Archived Issues
The Medicines Company reports results from second phase III trial of oritavancin for ABSSSI
Read More
Results from phase III trials of dolutegravir presented
Read More
Etubics receives NIH grant to develop HPV vaccine
Read More
Covidien separates pharmaceuticals business
Read More
Array BioPharma commences phase III study of MEK-162 in LGSOC
Read More
FEN1 gene expression associated with adverse breast and ovarian cancer characteristics
Read More
Phase I study of OTS-167 to begin in the U.S.
Read More
Catabasis Pharmaceuticals synthesizes new agents for viral infections
Read More
Noninvasive method to determine the genetic basis of acquired resistance to cancer drugs
Read More
Purdue Pharma presents novel opioid receptor agonists and antagonists
Read More
VentiRx begins new phase II trial of VTX-2337 in combination therapy for head and neck cancer
Read More
Novavax reports encouraging topline results from phase I trial of RSV vaccine in the elderly
Read More
Avanir and OptiNose enter development and commercialization agreement
Read More
Initiation of a phase III study of ITK-1 in patients with prostate cancer
Read More
Markers of cancer response to treatments including bevacizumab identified
Read More
Phase I/II study of Pergamum's LL-37 in chronic leg ulcers meets primary endpoint
Read More
Blaze Bioscience and Fred Hutchinson Cancer Research Center enter optides agreement
Read More
Gates Foundation provides phase II funding to MicroCubes vaccine project
Read More
Nanobiotix receives funding from bpifrance as part of grant to support nanomedicine consortium
Read More
GSK set to initiate phase III study of ofatumumab in rare skin disorder
Read More
Australian group presents novel metal complexes for Alzheimer's disease
Read More
Merck & Co. presents new JAK3 inhibitors
Read More
R-Pharm acquires worldwide license to olokizumab from UCB
Read More
ANO3 gene mutations implicated in primary cranio-cervical dystonia
Read More
Researchers at Boehringer Ingelheim divulge new mGlu5 positive allosteric modulators
Read More